CD19 POSITIVE
Clinical trials for CD19 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CD19 POSITIVE trials appear
Sign up with your email to follow new studies for CD19 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough blood cancers
Disease control OngoingThis early-phase study tests a treatment that uses a patient's own immune cells, modified to recognize and attack cancer cells, for adults with B-cell blood cancers that have returned or not responded to standard therapy. The treatment is given with chemotherapy and sometimes an …
Matched conditions: CD19 POSITIVE
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
Double-targeted cell therapy takes on hard-to-treat blood cancers
Disease control OngoingThis early-phase trial is testing a new type of immunotherapy for people with certain blood cancers (like lymphoma and leukemia) that have returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are modified in a lab to recogniz…
Matched conditions: CD19 POSITIVE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC